文献速递头颈部肿瘤放疗放疗物理与技术

IVIM磁共振监测鼻咽癌放疗相关甲状腺功能减退的潜在价值

The potential value of IVIM MR for radiation-related hypothyroidism in nasopharyngeal carcinoma.
PubMed 文献 · Radiother Oncol · 2025-07-30

本研究纳入48例接受调强放疗的鼻咽癌患者,在放疗前、中、后行IVIM磁共振检查并定期评估甲状腺功能。14例(29.2%)发生甲状腺功能减退,中位发生时间为治疗后7个月;放疗1年后45例存活者中12例(26.7%)发生甲减。D值在放疗期间逐渐升高,前半程升高幅度显著大于后半程(9.50% vs. 0.94%,p=0.003);女性、N3分期和ΔDhalf(%)是放疗1年后甲减的独立危险因素,并据此构建了列线图。

要点

  • 鼻咽癌调强放疗后甲减发生率高且潜伏期短,中位7个月。
  • IVIM的D值在放疗期间逐渐升高,前半程升高更快。
  • 女性、N3分期和ΔDhalf(%)是放疗1年后甲减的独立危险因素。

核心结论

  • 鼻咽癌调强放疗后甲减发生率高且潜伏期短,女性或N3期患者制定计划时应尽量降低甲状腺受量。
  • IVIM磁共振有望动态监测放射性甲状腺损伤,ΔDhalf(%)有潜力早期预测放疗1年后的甲减。

研究设计与样本

  • 前瞻性纳入符合条件的鼻咽癌患者,在调强放疗前、放疗中途和放疗完成时行IVIM磁共振检查。
  • 放疗前后定期评估甲状腺功能,分析IVIM参数(D、D*、f)在放疗期间的变化及其与甲减的关联。
  • 共纳入48例患者。

主要发现

  • 14例(14/48,29.2%)发生甲减,中位发生时间为治疗后7个月。
  • 45例存活者中12例(12/45,26.7%)在调强放疗1年后发生甲减。
  • D值在调强放疗期间逐渐升高(p < 0.001),前半程升高幅度显著大于后半程(9.50% vs. 0.94%,p = 0.003)。
  • D*值在调强放疗期间先升高后降低(p = 0.036)。
  • 女性、N3分期和ΔDhalf(%)被确定为调强放疗1年后甲减的独立危险因素,并构建了性能良好的列线图。

关键数值与推荐

  • 甲减发生率为29.2%(14/48),中位发生时间7个月。
  • 调强放疗1年后存活者甲减发生率为26.7%(12/45)。
  • D值升高p < 0.001;前半程与后半程升高幅度比较p = 0.003;D*变化p = 0.036。
  • 甲减1年独立危险因素:女性、N3分期、ΔDhalf(%)。

临床怎么用

  • 对女性或N3分期的鼻咽癌患者制定调强放疗计划时,应尽量降低甲状腺受量。
  • 可利用IVIM磁共振动态监测放疗相关甲状腺损伤,ΔDhalf(%)可用于早期预测放疗1年后的甲减风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: This study aimed to evaluate the value of intravoxel incoherent motion (IVIM) magnetic resonance (MR) in monitoring radiation-induced thyroid injury and predicting the risk of hypothyroidism (HT) for patients with nasopharyngeal carcinoma (NPC) undergoing intensity-modulated radiotherapy (IMRT). MATERIALS AND METHODS: Eligible patients were enrolled and underwent IVIM MR before, halfway through, and upon completion of IMRT. Thyroid function was assessed periodically before and after treatment. The changes in IVIM parameters (D, D*, and f) throughout IMRT and their association with HT were analyzed. RESULTS: A total of 48 patients were recruited, and 14 (14/48, 29.2 %) developed HT, with a median onset time of 7 months following treatment. 12 of the 45 surviving patients (12/45, 26.7 %) developed HT 1 year after IMRT. The D gradually increased during IMRT (p < 0.001), with the rate of increase in the first half of IMRT significantly greater than that in the second half (9.50 % vs. 0.94 %, p = 0.003). The D* initially increased and subsequently decreased during IMRT (p = 0.036). Female, N3 stage, and ΔDhalf(%) were identified as independent risk factors for HT 1 year after IMRT. A nomogram was developed with favorable performance and accuracy. CONCLUSIONS: A high incidence of HT with a short latency period is still observed in NPC. When formulating IMRT plan for female or N3 stage NPC, efforts should be made to minimize the thyroid exposure. IVIM MR shows promise as a tool for dynamically monitoring radiation-related thyroid injury, with ΔDhalf(%) demonstrating potential for early prediction of HT 1 year after IMRT.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Yang C, Shen M, Long L, et al. The potential value of IVIM MR for radiation-related hypothyroidism in nasopharyngeal carcinoma. Radiother Oncol. 2025. PMID: 40750016. doi:10.1016/j.radonc.2025.111065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。